Perrigo Co's average Accounts Receivable for the
three
months ended in Jun. 2022 was $715 Mil. Perrigo Co's Revenue for the
three
months ended in Jun. 2022 was $1,122 Mil.
Hence, Perrigo Co's Days Sales Outstanding for the
three
months ended in Jun. 2022 was 58.15.
The historical rank and industry rank for Perrigo Co's Days Sales Outstanding or its related term are showing as below:
PRGO'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.96 Med: 82.22 Max: 109.23
Current: 56.95
During the past 13 years, Perrigo Co's highest Days Sales Outstanding was 109.23. The lowest was 54.96. And the median was 82.22.
PRGO's Days Sales Outstanding is ranked better than 64.76% of 1030
companies
in the Drug Manufacturers industry
Industry Median: 68.84
vs PRGO: 56.95
Perrigo Co's Days Sales Outstanding
declined
from Jun. 2021 (58.65) to Jun. 2022 (58.15).
Perrigo Co Days Sales Outstanding Historical Data
The historical data trend for Perrigo Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Perrigo Co Annual Data
Trend
Jun12
Jun13
Jun14
Jun15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Days Sales Outstanding
85.11
85.00
109.23
81.99
54.96
Perrigo Co Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Days Sales Outstanding
58.65
57.16
55.30
56.57
58.15
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co Days Sales Outstanding Distribution
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Days Sales Outstanding falls into.
Perrigo Co Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (NYSE:PRGO) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Perrigo Co Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Perrigo Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.39(3.51%) Volume: 1,591,200 10:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:PRGO has been successfully added to your 
